Strides Pharma Science Ltd.
Fundamentals
- Market cap
- ₹10,629 cr
- P/E
- 19.11×
- ROE
- 140.82%
- Debt / equity
- 0.70
- Div yield
- 0.43%
- 52-week range
- 688.75 — 1231.00
The timeline — 2 notes on Strides Pharma Science Ltd.
May 2026
- 21 May 26 · 13:55 IST Brief Brief · Earnings
Strides Pharma Q4 transcript: nothing new from May 18 call
The earnings call transcript filed today reiterates the US revenue aspiration of $375-400M and strong ex-US growth, all of which were shared during the live call and in the subsequent summary.
- 20 May 26 · 22:03 IST Brief Brief
Strides Pharma's flagship plant draws 5 FDA observations
A Form 483 at the company's main manufacturing site raises the stakes for a warning letter or import ban. Response due in 15 days.